Niagen Bioscience Inc (NAGE)
NASDAQ: NAGE
· Real-Time Price · USD
13.71
-0.11 (-0.80%)
At close: Jun 27, 2025, 2:48 PM
-0.80% (1D)
| Bid | 13.7 |
| Market Cap | 1.08B |
| Revenue (ttm) | 107.92M |
| Net Income (ttm) | 14.11M |
| EPS (ttm) | 0.18 |
| PE Ratio (ttm) | 76.17 |
| Forward PE | 56 |
| Analyst | Strong Buy |
| Ask | 13.73 |
| Volume | 558,047 |
| Avg. Volume (20D) | 884,075 |
| Open | 13.81 |
| Previous Close | 13.82 |
| Day's Range | 13.35 - 13.94 |
| 52-Week Range | 2.40 - 14.49 |
| Beta | 2.08 |
About NAGE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NAGE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NAGE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Niagen Bioscience Inc is scheduled to release its earnings on Aug 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+12.51%
Niagen Bioscience shares are trading higher after ...
Unlock content with
Pro Subscription
1 month ago
+9.35%
Niagen Bioscience shares are trading higher after the company reported better-than-expected Q1 financial results and raised its fY25 revenue guidance.
2 weeks ago · businesswire.com
Niagen Bioscience to Participate in the BIO 2025 International ConventionLOS ANGELES--(BUSINESS WIRE)---- $NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the...
